 | • レポートコード：MRC309Z7901 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のラコサミド錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のラコサミド錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ラコサミド錠の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ラコサミド錠市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・50mg/錠、100mg/錠、150mg/錠、200mg/錠 用途別セグメント ・大人、子供 主要な市場プレーヤー ・UCB、Aesica Pharmaceuticals GmbH、Teva、MSN Laboratories、Alembic Pharma、Glenmark、Accord Healthcare、Mylan、Sun PharmaApotex、Jiangxi Qingfeng Pharmaceutical、Beijing Sihuan Pharmaceutical、Buchang Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ラコサミド錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なラコサミド錠メーカーの企業概要、2019年～2022年までのラコサミド錠の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なラコサミド錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ラコサミド錠の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのラコサミド錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのラコサミド錠市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびラコサミド錠の産業チェーンを掲載しています。 ・第14、15章では、ラコサミド錠の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ラコサミド錠の概要 - 種類別分析（2018年vs2022年vs2029年）：50mg/錠、100mg/錠、150mg/錠、200mg/錠 - 用途別分析（2018年vs2022年vs2029年）：大人、子供 - 世界のラコサミド錠市場規模・予測 - 世界のラコサミド錠生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - UCB、Aesica Pharmaceuticals GmbH、Teva、MSN Laboratories、Alembic Pharma、Glenmark、Accord Healthcare、Mylan、Sun PharmaApotex、Jiangxi Qingfeng Pharmaceutical、Beijing Sihuan Pharmaceutical、Buchang Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：50mg/錠、100mg/錠、150mg/錠、200mg/錠 ・用途別分析2018年-2029年：大人、子供 ・ラコサミド錠の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ラコサミド錠のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ラコサミド錠のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ラコサミド錠の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ラコサミド錠の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Lacosamide Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs (“complementary therapy”) to treat focal seizures (seizures that start in one area of the brain).
This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lacosamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lacosamide Tablets market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories and Alembic Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lacosamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Market segment by Application
Adults
Children
Major players covered
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales, revenue and global market share of Lacosamide Tablets from 2018 to 2023.
Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lacosamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Lacosamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg/tablet
1.3.3 100 mg/tablet
1.3.4 150 mg/tablet
1.3.5 200 mg/tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Lacosamide Tablets Market Size & Forecast
1.5.1 Global Lacosamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lacosamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Lacosamide Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Tablets Product and Services
2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 UCB Recent Developments/Updates
2.2 Aesica Pharmaceuticals GmbH
2.2.1 Aesica Pharmaceuticals GmbH Details
2.2.2 Aesica Pharmaceuticals GmbH Major Business
2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Lacosamide Tablets Product and Services
2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alembic Pharma Recent Developments/Updates
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Tablets Product and Services
2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Recent Developments/Updates
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Accord Healthcare Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Lacosamide Tablets Product and Services
2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 Sun PharmaApotex
2.9.1 Sun PharmaApotex Details
2.9.2 Sun PharmaApotex Major Business
2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun PharmaApotex Recent Developments/Updates
2.10 Jiangxi Qingfeng Pharmaceutical
2.10.1 Jiangxi Qingfeng Pharmaceutical Details
2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
2.11 Beijing Sihuan Pharmaceutical
2.11.1 Beijing Sihuan Pharmaceutical Details
2.11.2 Beijing Sihuan Pharmaceutical Major Business
2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
2.12 Buchang Pharmaceutical
2.12.1 Buchang Pharmaceutical Details
2.12.2 Buchang Pharmaceutical Major Business
2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Buchang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Lacosamide Tablets by Manufacturer
3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lacosamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Lacosamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Lacosamide Tablets Manufacturer Market Share in 2022
3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Lacosamide Tablets Market: Region Footprint
3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Lacosamide Tablets Market Size by Region
4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Lacosamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Lacosamide Tablets Average Price by Region (2018-2029)
4.2 North America Lacosamide Tablets Consumption Value (2018-2029)
4.3 Europe Lacosamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029)
4.5 South America Lacosamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Lacosamide Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Lacosamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Lacosamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Lacosamide Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Lacosamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Lacosamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Lacosamide Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Lacosamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Lacosamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Lacosamide Tablets Market Size by Country
7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Lacosamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Lacosamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Lacosamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Lacosamide Tablets Market Size by Country
8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Lacosamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Lacosamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Lacosamide Tablets Market Size by Country
10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Lacosamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Lacosamide Tablets Market Drivers
12.2 Lacosamide Tablets Market Restraints
12.3 Lacosamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lacosamide Tablets
13.3 Lacosamide Tablets Production Process
13.4 Lacosamide Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lacosamide Tablets Typical Distributors
14.3 Lacosamide Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer